Positive Phase III Data for Genentech’s Gazyva Show Significant Reduction in Disease Activity for Systemic Lupus Erythematosus
– Phase III ALLEGORY study met primary and all key secondary endpoints with Gazyva, an more...
– Phase III ALLEGORY study met primary and all key secondary endpoints with Gazyva, an more...
Samsung Epis Holdings to be listed on Korea Exchange (KRX) on November 24, 2025 Samsung more...
Relief flight departs Miami’s Airport, Monday, November 3rd Cargo will be loaded at 8:00 am more...
Patients nationwide can access faster, convenient TMS treatment.COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Serenity Mental Health Centers, a more...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology more...
BOCA RATON, Fla.--(BUSINESS WIRE)--$CELH #LiveFit--Celsius Holdings, Inc. (Nasdaq: CELH) will release its third quarter financial more...
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare more...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced the U.S. Federal Trade Commission has granted more...
Federally Qualified Health Centers stand out among Aledade partners that receive American Heart Association and more...
IRVINE, Calif.--(BUSINESS WIRE)--#biologics--Immunis, Inc., a clinical-stage biotech developing innovative stem cell-derived biologics for age- and more...